Prostate Cancer Clinical Decision Making by Diagnosed and High Risk Latino Men

确诊和高危拉丁裔男性的前列腺癌临床决策

• 批准号: 7531018
• 负责人: SALLY L Maliski
• 金额: $ 19.25万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-26 至 2010-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7531018
• 关键词: Accounting; Acculturation; Address; Attention; Attitude; Belief; Brothers; California; Caucasians; Caucasoid Race; Cause of Death; Clinical; Consensus; Country; Data; Decision Making; Depth; Development; Diagnosis; Disadvantaged; Disclosure; Disease; Early treatment; Education; Face; Feeling; First Degree Relative; Foundations; Future; Healthcare; Hispanics; Immigrant; Individual; Intervention; Interview; Knowledge; Language; Latino; Life; Literature; Low income; Malignant neoplasm of prostate; Medical; Methods; Mexican; Mexican Americans; Minority; Modeling; Perception; Population; Process; Public Health; Purpose; Rate; Reporting; Research; Review Literature; Risk; Role; Screening for Prostate Cancer; Screening procedure; Second Primary Cancers; Son; Source; Staging; Treatment outcome; Uncertainty; Uninsured; United States; Variant; Writing; base; cancer therapy; coping; experience; high risk men; men; men' s group; mortality; social disparities

DESCRIPTION (provided by applicant): Prostate cancer is the most common noncutaneous cancer and second leading cause of death among men in the United States, and Latinos are the fastest growing minority in the United States. However, low income Latino men are more likely to be uninsured, have less education, and have lower incomes. Many do not speak English as their first language. For these men, much of the available information to help with informed decision-making is not accessible. Because of the lack of consensus on the benefits of screening on prostate cancer mortality or of superior survival benefit of any one treatment for early stage prostate cancer, men are faced with life-altering decisions regarding screening and treatment for those who are diagnosed. Furthermore, men with a first degree relative with prostate cancer are at increased risk. Yet, how the rapidly growing population of Latino men approaches the decision-making process in prostate cancer is virtually unknown. Therefore, the overall purpose of this study is to develop descriptive models of prostate cancer screening, treatment, and diagnosis disclosure decision-making from the perspective of Latino men to form an evidence base for the development of culturally appropriate intervention strategies to facilitate informed and confident decision-making. Specifically, we aim to: 1. Describe the process of deciding on treatment and disclosing diagnosis from the perspective of Latino men who have been treated for prostate cancer and 2. Describe the process of deciding to be screened or not screened for prostate cancer by brothers or sons of Latino men diagnosed with prostate cancer. We will use qualitative descriptive methods to understand prostate cancer treatment, disclosure, and screening decision-making processes from the perspective of Latino men. Both specific aims will be addressed with in-depth individual interviews exploring involvement in and comfort with treatment decision making process, influences on the decision, and disclosure of diagnosis by treated men. For high risk men we will explore risk perception, knowledge and beliefs about prostate cancer screening, sources of information, facilitators and barriers, and decision implementation. Analyses will result in clear, in-depth descriptions that will guide the future development of intervention strategies to facilitate informed decision-making regarding prostate cancer treatment, disclosure, and screening among Latino men facing prostate cancer decisions. PUBLIC HEALTH RELEVANCE: The relevance of this study to public health lies in the fact that Latinos are the fastest growing minority in the United States and Mexican/Mexican-Americans make up over 70% of this growing Latino population. Understanding how treatment, disclosure, and screening decisions are made by Mexican/Mexican-American men from this research will lay the foundation for culturally relevant interventions to assist these men as they face life-altering decisions. Potentially, informed, confident decision-making participation may contribute to better treatment outcomes and appropriate screening for this disadvantaged group of men.

描述（由申请人提供）：前列腺癌是美国男性中最常见的非皮肤癌和第二大死亡原因，拉丁美洲人是美国增长最快的少数民族。然而，低收入的拉丁裔男性更有可能没有保险，受教育程度较低，收入较低。许多人不把英语作为他们的第一语言。对这些人来说，帮助他们作出知情决策的许多现有信息是无法获得的。由于对筛查对前列腺癌死亡率的益处或任何一种早期前列腺癌治疗的上级生存益处缺乏共识，男性面临着关于诊断的筛查和治疗的改变生活的决定。此外，与前列腺癌有一级亲属的男性风险增加。然而，快速增长的拉丁裔男性人口如何处理前列腺癌的决策过程几乎是不可能的。 未知因此，本研究的总体目的是从拉丁美洲男性的角度开发前列腺癌筛查，治疗和诊断披露决策的描述性模型，以形成制定文化上适当的干预策略的证据基础，以促进知情和自信的决策。具体而言，我们的目标是：1。描述决定治疗和披露诊断的过程中，从拉丁美洲男性谁已经接受前列腺癌治疗的角度和2。描述被诊断患有前列腺癌的拉丁美洲男性的兄弟或儿子决定接受前列腺癌筛查或不筛查的过程。我们将使用定性描述方法来了解前列腺癌的治疗，披露和筛选决策过程从拉丁美洲男性的角度来看。这两个具体目标将通过深入的个人访谈来解决，探讨参与和舒适的治疗决策 过程，对决定的影响，以及接受治疗的男性对诊断的披露。对于高危人群， 将探讨风险认知，知识和信念有关前列腺癌筛查，信息来源，促进者和障碍，以及决策执行。分析将导致清晰，深入的描述，这将指导干预策略的未来发展，以促进知情决策有关前列腺癌的治疗，披露，并面临前列腺癌的拉丁美洲男性之间的筛选决定。公共卫生关系：这项研究与公共卫生的相关性在于，拉丁美洲人是美国增长最快的少数民族，墨西哥人/墨西哥裔美国人占拉丁美洲人口增长的70%以上。从这项研究中了解墨西哥/墨西哥裔美国人如何做出治疗，披露和筛查决定，将为文化相关的干预措施奠定基础，以帮助这些人做出改变生活的决定。潜在的、知情的、自信的决策参与可能有助于 更好的治疗结果和适当的筛查，为这一弱势群体的男子。